Gujarat Themis Biosyn Limited (NSE:GUJTHEM)
India · Delayed Price · Currency is INR 387.00
+19.30 (5.25%)
Last updated: Jul 29, 2025
Exscientia Market Cap
Gujarat Themis Biosyn has a market cap or net worth of 42.60 billion as of August 1, 2025. Its market cap has increased by 20.92% in one year.
Market Cap
42.60B
Enterprise Value
42.78B
Revenue
1.51B
Ranking
n/a
PE Ratio
87.35
Stock Price
$387.00
Market Cap Chart
Since January 2, 2002, Gujarat Themis Biosyn's market cap has increased from 34.80M to 42.60B, an increase of 122,314.01%. That is a compound annual growth rate of 35.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2025 | 42.60B | 27.99% |
| Dec 31, 2024 | 33.28B | 78.59% |
| Dec 29, 2023 | 18.64B | 65.76% |
| Dec 30, 2022 | 11.24B | 62.30% |
| Dec 31, 2021 | 6.93B | 89.96% |
| Dec 31, 2020 | 3.65B | 323.99% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4,094.94B |
| Divi's Laboratories | 1,750.90B |
| Cipla | 1,255.73B |
| Apollo Hospitals Enterprise | 1,078.10B |
| Mankind Pharma | 1,059.56B |
| Zydus Lifesciences | 975.85B |
| Aurobindo Pharma | 662.00B |
| Fortis Healthcare | 647.34B |